Tak-603, new rheumatic drug, inhibits rat mixed lymphocyte reactions and prolonges rat skin allograft survival
To access this article, please choose from the options below
PII: S0041-1345(02)02810-5
© 2002 Elsevier Science Inc. All rights reserved.
PII: S0041-1345(02)02810-5
© 2002 Elsevier Science Inc. All rights reserved.